跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Deucravacitinib Tablets
Approved
化学药品
Deucravacitinib Tablets
Bristol-Myers Squibb Pharma EEIG
🇨🇳 National Medical Products Administration
Approval Date
Feb 22, 2024
Approval ID
8VIaJ4PIBbz
Company
Bristol-Myers Squibb Pharma EEIG
Type
化学药品
Approval Details
Approval Id
8VIaJ4PIBbz
Approval Number
国药准字HJ20230120
Generic Name
氘可来昔替尼片
Generic Name En
Deucravacitinib Tablets
Trade Name
颂狄多
Drug Type
化学药品
Dosage Form
片剂
Strength
6mg
Reg Date
2024-02-22
Expired Date
2028-10-17
Company Name
Bristol-Myers Squibb Pharma EEIG
Production Company Name
Patheon Inc
Company Detail Path
/organization/bristol-myers-squibb-pharma-eeig
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 22, 2024
Approval ID
8VIaJ4PIBbz
Type
化学药品
Back to NMPA Approvals
颂狄多 - NMPA Drug Approval Details